Doximity, Inc. (NASDAQ:DOCS) Director Kira Scherer Wampler Sells 2,000 Shares

Key Points

• Director Kira Scherer Wampler sold 2,000 shares of Doximity stock for a total of $114,180.00, decreasing her position by 10.74%.
• Doximity shares are currently valued at $57.30 after a slight decline, with a market capitalization of $10.76 billion and a P/E ratio of 57.30.
• Recent analyst reports led to varying target price adjustments for Doximity, with the consensus target now at $64.89 and a rating of "Moderate Buy."

Doximity, Inc. (NASDAQ:DOCS - Get Free Report) Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares in the company, valued at approximately $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Kira Scherer Wampler also recently made the following trade(s):

• On Monday, June 2nd, Kira Scherer Wampler sold 2,000 shares of Doximity stock. The stock was sold at an average price of $52.89, for a total transaction of $105,780.00.
• On Monday, June 2nd, Kira Scherer Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $52.89, for a total transaction of $105,780.00.

Doximity Stock Performance

Shares of DOCS traded down $0.32 during mid-day trading on Tuesday, hitting $57.98. 544,378 shares of the stock were exchanged, compared to its average volume of 2,340,526. The company has a market cap of $10.89 billion, a PE ratio of 58.09, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a 52-week low of $25.36 and a 52-week high of $85.21. The firm has a 50-day moving average of $58.53 and a two-hundred day moving average of $59.92.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings data on Thursday, May 15th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.11. Doximity had a return on equity of 21.75% and a net margin of 36.60%. The firm's revenue was up 17.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.25 EPS. On average, sell-side analysts predict that Doximity, Inc. will post 0.99 EPS for the current year.

Hedge Funds Weigh In On Doximity

Several large investors have recently modified their holdings of DOCS. Ballentine Partners LLC bought a new position in Doximity in the 1st quarter valued at $201,000. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Doximity by 196.6% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 13,570 shares of the company's stock worth $787,000 after purchasing an additional 8,995 shares during the last quarter. Range Financial Group LLC purchased a new stake in Doximity in the first quarter valued at about $916,000. New York State Teachers Retirement System raised its stake in Doximity by 10.9% in the first quarter. New York State Teachers Retirement System now owns 113,145 shares of the company's stock valued at $6,566,000 after buying an additional 11,078 shares during the last quarter. Finally, Wells Fargo & Company MN raised its stake in shares of Doximity by 3.3% in the fourth quarter. Wells Fargo & Company MN now owns 368,941 shares of the company's stock worth $19,698,000 after purchasing an additional 11,811 shares during the last quarter. Institutional investors own 87.19% of the company's stock.

Analyst Upgrades and Downgrades

DOCS has been the topic of a number of recent research reports. Truist Financial increased their price target on shares of Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a research report on Thursday, July 17th. Mizuho dropped their price target on Doximity from $65.00 to $60.00 and set a "neutral" rating for the company in a research note on Friday, May 16th. JPMorgan Chase & Co. lowered their price target on Doximity from $63.00 to $60.00 and set a "neutral" rating for the company in a research report on Tuesday, May 27th. BTIG Research raised Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target for the company in a research report on Monday, June 2nd. Finally, Canaccord Genuity Group reduced their price objective on Doximity from $71.00 to $50.00 and set a "hold" rating for the company in a report on Friday, May 16th. Ten analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $65.26.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.